Age-related declines in delayed non-match-to-sample performance (DNMS) are reversed by the novel 5HT6 receptor antagonist SB742457
- Charlotte K. Callaghan
- , Vincent Hok
- , Andrea Della-Chiesa
- , David J. Virley
- , Neil Upton
- , Shane M. O'Mara
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.